Fecal impaction (FI) is a common cause of lower gastrointestinal tract obstruction, and it is the result of chronic or severe constipation and most commonly found in the elderly population. Gastrografin is a water soluble contrast mediate that could act as an osmotic laxative. It has been shown to confer a therapeutic benefit in adhesive small bowel obstruction (SBO). The investigators speculate that gastrografin administrated orally may be more effective than enema in the treatment of fecal impaction induced intestinal obstruction.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
83
Department of Generay Surgery, Jinling hosptal, Medical School of Nanjing University
Nanjing, Jiangsu, China
the proportion of patients having successful disimpaction
Successful disimpaction was indicated by the passage of watery stools.
Time frame: 6 days
the time when patients having successful disimpaction
Successful disimpaction was indicated by the passage of watery stools.
Time frame: 6 days
Wexner constipation score
Severity of constipation symptoms was evaluated according to Wexner constipation scale.
Time frame: 6 days
Patient Assessment of Constipation-Symptoms (PAC-SYM) score
Severity of constipation symptoms was evaluated according to PAC-SYM questionnaire.
Time frame: 6 days
Patient Assessment of Constipation Quality of Life (PAC-QOL) score
Health-related quality of life was assessed using the trial by the PAC-QOL questionnaire.
Time frame: 6 days
adverse events and safety
Time frame: 6 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.